{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:20:44Z","timestamp":1740144044976,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T00:00:00Z","timestamp":1507939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"JSPS KAKENHI","award":["JP26670544"],"award-info":[{"award-number":["JP26670544"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s40261-017-0583-3","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T07:34:20Z","timestamp":1507966460000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improvements in Quality-Adjusted Life Years and Cost\u2013Utility After Pharmacotherapy for Premenstrual Dysphoric Disorder: A Retrospective Study"],"prefix":"10.1007","volume":"38","author":[{"given":"Eiichiro","family":"Kamagata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9219-6108","authenticated-orcid":false,"given":"Kazuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,14]]},"reference":[{"key":"583_CR1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013.","edition":"5"},{"key":"583_CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1192\/bjp.bp.106.025106","volume":"190","author":"SI Saarni","year":"2007","unstructured":"Saarni SI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, Lonnqvist J. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry. 2007;190:326\u201332.","journal-title":"Br J Psychiatry"},{"key":"583_CR3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s10157-010-0304-1","volume":"14","author":"R Tajima","year":"2010","unstructured":"Tajima R, Kondo M, Kai H, Saito C, Okada M, Takahashi H, Doi M, Tsuruoka S, Yamagata K. Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D). Clin Exp Nephrol. 2010;14:340\u20138.","journal-title":"Clin Exp Nephrol"},{"key":"583_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jad.2012.11.033","volume":"147","author":"M Subramaniam","year":"2013","unstructured":"Subramaniam M, Abdin E, Vaingankar JA, Nan L, Heng D, McCrone P, Chong SA. Impact of psychiatric disorders and chronic physical conditions on health-related quality of life: Singapore Mental Health Study. J Affect Disord. 2013;147:325\u201330.","journal-title":"J Affect Disord"},{"key":"583_CR5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1369-7625.2012.00765.x","volume":"17","author":"F Saleem","year":"2014","unstructured":"Saleem F, Hassali MA, Shafie AA. A cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in Pakistan. Health Expect. 2014;17:388\u201395.","journal-title":"Health Expect"},{"key":"583_CR6","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.4088\/JCP.14m09271","volume":"76","author":"K Penner-Goeke","year":"2015","unstructured":"Penner-Goeke K, Henriksen CA, Chateau D, Latimer E, Sareen J, Katz LY. Reductions in quality of life associated with common mental disorders: results from a nationally representative sample. J Clin Psychiatry. 2015;76:1506\u201312.","journal-title":"J Clin Psychiatry"},{"key":"583_CR7","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s11136-015-0964-0","volume":"24","author":"F Yang","year":"2015","unstructured":"Yang F, Griva K, Lau T, Vathsala A, Lee E, Ng HJ, Mooppil N, Foo M, Newman SP, Chia KS, Luo N. Health-related quality of life of Asian patients with end-stage renal disease (ESRD) in Singapore. Qual Life Res. 2015;24:2163\u201371.","journal-title":"Qual Life Res"},{"key":"583_CR8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/AOG.0b013e31816fd73b","volume":"111","author":"NR Shah","year":"2008","unstructured":"Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borenstein J. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol. 2008;111:1175\u201382.","journal-title":"Obstet Gynecol"},{"key":"583_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/jwh.2006.15.57","volume":"15","author":"M Steiner","year":"2006","unstructured":"Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health. 2006;15:57\u201369.","journal-title":"J Womens Health"},{"key":"583_CR10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bmj.38887.558576.7C","volume":"333","author":"J O\u2019Reilly","year":"2006","unstructured":"O\u2019Reilly J, Lowson K, Young J, Forster A, Green J, Small N. A cost effectiveness analysis within a randomised controlled trial of post-acute care of older people in a community hospital. BMJ. 2006;333:228.","journal-title":"BMJ"},{"key":"583_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/ageing\/afn120","volume":"37","author":"J O\u2019Reilly","year":"2008","unstructured":"O\u2019Reilly J, Lowson K, Green J, Young JB, Forster A. Post-acute care for older people in community hospitals\u2014a cost-effectiveness analysis within a multi-centre randomised controlled trial. Age Ageing. 2008;37:513\u201320.","journal-title":"Age Ageing"},{"key":"583_CR12","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1111\/j.1524-4733.2009.00629.x","volume":"12","author":"H Nagase","year":"2009","unstructured":"Nagase H, Moriwaki K, Kamae M, Yanagisawa S, Kamae I. Cost-effectiveness analysis of oseltamivir for influenza treatment considering the virus emerging resistant to the drug in Japan. Value Health. 2009;12:S62\u20135.","journal-title":"Value Health"},{"key":"583_CR13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/neuonc\/nos062","volume":"14","author":"JC Furlan","year":"2012","unstructured":"Furlan JC, Chan KK, Sandoval GA, Lam KC, Klinger CA, Patchell RA, Laporte A, Fehlings MG. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost\u2013utility analysis. Neuro Oncol. 2012;14:631\u201340.","journal-title":"Neuro Oncol"},{"key":"583_CR14","doi-asserted-by":"crossref","first-page":"e42003","DOI":"10.1371\/journal.pone.0042003","volume":"7","author":"J Ramsberg","year":"2012","unstructured":"Ramsberg J, Asseburg C, Henriksson M. Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model. PLoS One. 2012;7:e42003.","journal-title":"PLoS One"},{"key":"583_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/lary.24916","volume":"125","author":"L Rudmik","year":"2015","unstructured":"Rudmik L, Soler ZM, Mace JC, Schlosser RJ, Smith TL. Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015;125:25\u201332.","journal-title":"Laryngoscope"},{"key":"583_CR16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12913-015-0817-0","volume":"15","author":"C Brettschneider","year":"2015","unstructured":"Brettschneider C, Luck T, Fleischer S, Roling G, Beutner K, Luppa M, Behrens J, Riedel-Heller SG, Konig HH. Cost-utility analysis of a preventive home visit program for older adults in Germany. BMC Health Serv Res. 2015;15:141.","journal-title":"BMC Health Serv Res"},{"key":"583_CR17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2165\/11532210-000000000-00000","volume":"8","author":"R Rendas-Baum","year":"2010","unstructured":"Rendas-Baum R, Yang M, Gricar J, Wallenstein GV. Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder. Appl Health Econ Health Policy. 2010;8:129\u201340.","journal-title":"Appl Health Econ Health Policy"},{"key":"583_CR18","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and statistical manual of mental disorders, fourth edition, text revision; DSM-IV-TR","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision; DSM-IV-TR. Washington, DC: American Psychiatric Press; 2000."},{"key":"583_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-017-1642-1","author":"K Yamada","year":"2017","unstructured":"Yamada K, Kamagata E. Reduction of quality adjusted life years (QALYs) in patients with premenstrual dysphoric disorder (PMDD). Qual Life Res. 2017;. doi:\n                        10.1007\/s11136-017-1642-1\n                        \n                    .","journal-title":"Qual Life Res"},{"key":"583_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQoL Group","year":"1990","unstructured":"EuroQoL Group. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"key":"583_CR21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hec.673","volume":"11","author":"A Tsuchiya","year":"2002","unstructured":"Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, Hamashima C, Hisashige A, Tamura M. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341\u201353.","journal-title":"Health Econ"},{"key":"583_CR22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.39308.560069.BE","volume":"335","author":"J Appleby","year":"2007","unstructured":"Appleby J, Devlin N, Parkin D. NICE\u2019s cost effectiveness threshold. BMJ. 2007;335:358\u20139.","journal-title":"BMJ"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-017-0583-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T10:53:06Z","timestamp":1515581586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-017-0583-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,14]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1007\/s40261-017-0583-3","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"type":"print","value":"1173-2563"},{"type":"electronic","value":"1179-1918"}],"subject":[],"published":{"date-parts":[[2017,10,14]]}}}